摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

氨氯地平杂质29 | 93848-82-9

中文名称
氨氯地平杂质29
中文别名
——
英文名称
N-acetylamlodipine
英文别名
2-<<2-(N-acetylamino)ethoxy>methyl>-4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine;2-[[2-(N-acetylamino)ethoxy]methyl]-4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine;3-Ethyl 5-Methyl 2-((2-acetamidoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate;3-O-ethyl 5-O-methyl 2-(2-acetamidoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
氨氯地平杂质29化学式
CAS
93848-82-9
化学式
C22H27ClN2O6
mdl
——
分子量
450.919
InChiKey
MRDCCTCXJCVQFK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    31
  • 可旋转键数:
    11
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    103
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    氨氯地平杂质29lead(IV) acetate 作用下, 以 二氯甲烷溶剂黄146 为溶剂, 反应 20.0h, 以91%的产率得到2-[2-(acetylamino)ethoxymethyl]-3-ethoxycarbonyl-4-(o-chlorophenyl)-5-methoxycarbonyl-6-methylpyridine
    参考文献:
    名称:
    乙酸铅 (IV) 对 Hantzsch 1,4-二氢吡啶的温和、选择性和高产氧化
    摘要:
    描述了在温和的反应条件下用乙酸铅 (IV) 芳构化 1, 4-二氢吡啶。该方法在不同取代吡啶的合成中选择性强、温和且通用。
    DOI:
    10.3987/com-04-10194
  • 作为产物:
    描述:
    氨氯地平乙酰辅酶A三乙醇胺乙二胺四乙酸 、 carnitine acetyltransferase 、 arylamine N-acetyltransferase 2*4, wild-type allele 、 乙酰基肉碱1,4-二巯基-2,3-丁二醇 作用下, 以 为溶剂, 反应 18.0h, 生成 氨氯地平杂质29
    参考文献:
    名称:
    芳胺 N-乙酰转移酶 NAT2 对内源脂肪胺进行意外乙酰化。
    摘要:
    N-乙酰基转移酶在异生物质(包括临床药物)的失活和清除中发挥着关键作用。NAT2被归类为芳胺N-乙酰转移酶,主要转化芳香胺、羟胺和肼。在此,我们证明人芳胺N-乙酰转移酶 NAT2 也乙酰化脂肪族内源胺。代谢组学分析和化学合成表明,与慢速乙酰化NAT2表型相比,表达快速乙酰化剂NAT2表型的人类细胞系中单乙酰化亚精胺和二乙酰化亚精胺的细胞内浓度增加。NAT2 对单乙酰化亚精胺的区域选择性N 8乙酰化回答了二乙酰亚精胺来源这一长期存在的问题。我们还发现了 NAT2 对结构多样的含烷基胺药物的选择性乙酰化,这可能会导致患者反应的变化。结果表明 NAT2 具有以前未知的功能和潜在的调节作用,我们建议应考虑对该酶进行重新分类。
    DOI:
    10.1002/anie.202005915
点击查看最新优质反应信息

文献信息

  • Dihydropyridines Potentiate ATP-Induced Currents Mediated by the Full-Length Human P2X5 Receptor
    作者:Ida C. Schiller、Kenneth A. Jacobson、Zhiwei Wen、Aparna Malisetty、Günther Schmalzing、Fritz Markwardt
    DOI:10.3390/molecules27061846
    日期:——

    The P2X5 receptor, an ATP-gated cation channel, is believed to be involved in tumor development, inflammatory bone loss and inflammasome activation after bacterial infection. Therefore, it is a worthwhile pharmacological target to treat the corresponding diseases, especially in minority populations that have a gene variant coding for functional homotrimeric P2X5 channels. Here, we investigated the effects of dihydropyridines on the human full-length P2X5 receptor (hP2X5FL) heterologously expressed in Xenopus oocytes using the two-microelectrode voltage clamp method. Agonist dependency, kinetics and permeation behavior, including Cl− permeability, were similar to hP2X5FL expressed in HEK293 or 1321N1 cells. Additionally, 1,4-dihydropyridines have been shown to interact with various other purinergic receptors, and we have examined them as potential hP2X5 modulators. Of seven commercially available and four newly synthesized dihydropyridines tested at hP2X5FL, only amlodipine exerted an inhibitory effect, but only at a high concentration of 300 µM. Isradipine and—even more—nimodipine stimulated ATP-induced currents in the low micromolar range. We conclude that common dihydropyridines or four new derivatives of amlodipine are not suitable as hP2X5 antagonists, but amlodipine might serve as a lead for future synthesis to increase its affinity. Furthermore, a side effect of nimodipine therapy could be a stimulatory effect on inflammatory processes.

    P2X5受体是一种ATP门控阳离子通道,被认为参与肿瘤发展、炎性骨质流失和细菌感染后的炎症小体激活。因此,它是治疗相应疾病的有价值的药理靶点,尤其是那些具有编码功能同三聚体P2X5通道的基因变异的少数族裔人群。在这里,我们使用两电极电压钳方法,在异种卵母中异种表达的人类全长P2X5受体(hP2X5FL)上研究了二氢吡啶对其的影响。激动剂依赖性、动力学和渗透行为,包括Cl−渗透性,与在HEK293或1321N1细胞中表达的hP2X5FL类似。此外,已经显示1,4-二氢吡啶与各种其他嘌呤受体相互作用,我们已将它们作为潜在的hP2X5调节剂进行了研究。在测试了七种商业上可获得的和四种新合成的二氢吡啶后,只有氨氯地平在高浓度300µM时产生了抑制作用。异丙地平和尼莫地平在低微摩尔范围内刺激了ATP诱导的电流。我们得出结论,常见的二氢吡啶或四个新的氨氯地平衍生物不适合作为hP2X5拮抗剂,但氨氯地平可能作为未来合成的引物来增加其亲和力。此外,尼莫地平治疗的一个副作用可能是对炎症过程的刺激作用。
  • Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists
    作者:David Alker、Simon F. Campbell、Peter E. Cross、Roger A. Burges、Anthony J. Carter、Donald G. Gardiner
    DOI:10.1021/jm00164a019
    日期:1990.2
    The preparation of a series of 1,4-dihydropyridines (DHPs) which have polar, acyclic, nonbasic substituents on an ethoxymethyl chain at the 2-position is described. In addition, in order to assess the effects of incorporating a basic center into DHPs of this type, a series of glycinamides were also prepared. The calcium antagonist activity on rat aorta of both these classes of DHP is compared with their negative inotropic activity as determined by using a Langendorff perfused guinea pig heart model. A number of the compounds evaluated have activity of the same order as nifedipine although those with more extended substituents have lower potency, particularly when a basic substituent is present. The compounds examined displayed a wide variation in selectivity for vascular over cardiac tissue. A number of structure-activity relationship trends were identified and possible explanations to account for the differences in selectivity observed are advanced. One of the compounds, 2-[[2-[[4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6- methyl-1,4-dihydropyrid-2-yl]methoxy]ethyl]amino]acetamide (26, UK-51,656), was identified as a potent (IC50 = 4 x 10(-9) M) calcium antagonist which is 20-fold selective for vascular over cardiac tissue and which has a markedly longer duration of action (greater than 5 h) than nifedipine in the anesthetized dog on intravenous administration. The pharmacokinetic half-life of 26 was established as 4.7 h and possible explanations are advanced to account for 26 having a shorter plasma half-life than amlodipine and a longer plasma half-life than felodipine.
  • ALKER, DAVID;CAMPBELL, SIMON F.;CROSS, PETER E.;BURGES, ROGER A.;CARTER, +, J. MED. CHEM., 33,(1990) N, C. 585-591
    作者:ALKER, DAVID、CAMPBELL, SIMON F.、CROSS, PETER E.、BURGES, ROGER A.、CARTER, +
    DOI:——
    日期:——
  • Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine <i>N</i> ‐Acetyltransferase NAT2
    作者:Louis P. Conway、Veronica Rendo、Mário S. P. Correia、Ingvar A. Bergdahl、Tobias Sjöblom、Daniel Globisch
    DOI:10.1002/anie.202005915
    日期:2020.8.17
    play critical roles in the deactivation and clearance of xenobiotics, including clinical drugs. NAT2 has been classified as an arylamine N‐acetyltransferase that mainly converts aromatic amines, hydroxylamines, and hydrazines. Herein, we demonstrate that the human arylamine N‐acetyltransferase NAT2 also acetylates aliphatic endogenous amines. Metabolomic analysis and chemical synthesis revealed increased
    N-乙酰基转移酶在异生物质(包括临床药物)的失活和清除中发挥着关键作用。NAT2被归类为芳胺N-乙酰转移酶,主要转化芳香胺、羟胺和肼。在此,我们证明人芳胺N-乙酰转移酶 NAT2 也乙酰化脂肪族内源胺。代谢组学分析和化学合成表明,与慢速乙酰化NAT2表型相比,表达快速乙酰化剂NAT2表型的人类细胞系中单乙酰化亚精胺和二乙酰化亚精胺的细胞内浓度增加。NAT2 对单乙酰化亚精胺的区域选择性N 8乙酰化回答了二乙酰亚精胺来源这一长期存在的问题。我们还发现了 NAT2 对结构多样的含烷基胺药物的选择性乙酰化,这可能会导致患者反应的变化。结果表明 NAT2 具有以前未知的功能和潜在的调节作用,我们建议应考虑对该酶进行重新分类。
  • Mild, Selective and High-Yield Oxidation of Hantzsch 1,4-Dihydropyridines with Lead(IV) Acetate
    作者:Mladen Litvić、Ivica Cepanec、Mirela Filipan、Karmen Kos、Anamarija Bartolinčić、Vinka Drušković、Mohamed Majed Tibi、Vladimir Vinković
    DOI:10.3987/com-04-10194
    日期:——
    Aromatization of 1, 4-dihydropyridines with lead(IV) acetate under mild reaction conditions is described. The method is very selective, mild and versatile in the synthesis of different substituted pyridines.
    描述了在温和的反应条件下用乙酸铅 (IV) 芳构化 1, 4-二氢吡啶。该方法在不同取代吡啶的合成中选择性强、温和且通用。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-